Уноси

• Clinical characteristics and managing type 2 diabetes during COVID 19 (2022-01)

  I. Risović, D. Djekic, B. Vukovic, V. Vlatković, Clinical characteristics and managing type 2 diabetes during COVID 19, Clinical Diabetology, Vol. 11, No. 1, pp. 20 - 25, Jan, 2022

• Direct comparison two fxed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes (2023)

  I. Risović, M. Sumarac Dumanovic, M. Bojic, D. Djekic, Direct comparison two fxed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes, BMC Endocrine Disorders, Vol. 23, No. 28, pp. 1 - 6, 2023

• Benefits of insulin glargine/lixisenatide fixed-ratio combination for patients inadequately controlled on premixed insulin and oral agents (2021-09)

  I. Risović, M. Bojic, D. Djekic, Benefits of insulin glargine/lixisenatide fixed-ratio combination for patients inadequately controlled on premixed insulin and oral agents, Diabetologia 64, 1–380 (2021), Sep, 2021